Farmers & Merchants Trust Co of Chambersburg PA lifted its position in Exelon Co. (NYSE:EXC) by 11.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 7,573 shares of the energy giant’s stock after purchasing an additional 800 shares during the period. Farmers & Merchants Trust Co of Chambersburg PA’s holdings in Exelon were worth $363,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the company. Livforsakringsbolaget Skandia Omsesidigt lifted its position in Exelon by 6.4% during the second quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 21,537 shares of the energy giant’s stock valued at $1,032,000 after buying an additional 1,300 shares during the period. Eqis Capital Management Inc. lifted its position in Exelon by 18.2% during the second quarter. Eqis Capital Management Inc. now owns 20,844 shares of the energy giant’s stock valued at $999,000 after buying an additional 3,205 shares during the period. Altium Wealth Management LLC lifted its position in Exelon by 19.2% during the second quarter. Altium Wealth Management LLC now owns 8,944 shares of the energy giant’s stock valued at $429,000 after buying an additional 1,442 shares during the period. Moors & Cabot Inc. lifted its position in Exelon by 6.5% during the second quarter. Moors & Cabot Inc. now owns 6,596 shares of the energy giant’s stock valued at $316,000 after buying an additional 404 shares during the period. Finally, Foundry Partners LLC lifted its position in Exelon by 31.1% during the second quarter. Foundry Partners LLC now owns 624,543 shares of the energy giant’s stock valued at $29,941,000 after buying an additional 148,215 shares during the period. Hedge funds and other institutional investors own 79.67% of the company’s stock.

In related news, CEO Calvin Butler, Jr. sold 31,000 shares of Exelon stock in a transaction dated Friday, June 28th. The stock was sold at an average price of $47.59, for a total value of $1,475,290.00. Following the completion of the sale, the chief executive officer now directly owns 40,331 shares in the company, valued at approximately $1,919,352.29. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Kenneth W. Cornew sold 54,300 shares of Exelon stock in a transaction dated Tuesday, June 18th. The stock was sold at an average price of $49.82, for a total value of $2,705,226.00. Following the completion of the sale, the executive vice president now owns 97,813 shares of the company’s stock, valued at $4,873,043.66. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by company insiders.

Several research firms have recently issued reports on EXC. Barclays reaffirmed a “top pick” rating and issued a GBX 3,250 ($42.47) price target on shares of in a research report on Wednesday, June 19th. Wells Fargo & Co set a $68.00 price target on Emergent Biosolutions and gave the stock a “hold” rating in a research report on Tuesday, April 2nd. ValuEngine raised Worldline from a “hold” rating to a “buy” rating in a research report on Tuesday, July 23rd. Goldman Sachs Group raised Exelon from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $48.00 to $52.00 in a research report on Thursday, June 6th. Finally, Morgan Stanley set a $18.00 price target on PG&E and gave the stock a “hold” rating in a research report on Friday, June 14th. Eight investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $49.96.

NYSE EXC traded up $0.14 during trading hours on Tuesday, hitting $46.19. The company’s stock had a trading volume of 1,252,705 shares, compared to its average volume of 5,543,646. Exelon Co. has a 12 month low of $41.65 and a 12 month high of $51.18. The stock has a 50 day moving average price of $48.65. The company has a market capitalization of $44.49 billion, a P/E ratio of 14.80, a P/E/G ratio of 4.08 and a beta of 0.37. The company has a debt-to-equity ratio of 0.99, a quick ratio of 0.89 and a current ratio of 1.02.

Exelon (NYSE:EXC) last released its quarterly earnings data on Thursday, May 2nd. The energy giant reported $0.87 EPS for the quarter, hitting the consensus estimate of $0.87. Exelon had a return on equity of 8.85% and a net margin of 6.52%. The company had revenue of $9.48 billion during the quarter, compared to the consensus estimate of $9.10 billion. During the same period last year, the company earned $0.96 EPS. Exelon’s revenue for the quarter was down 2.2% on a year-over-year basis. On average, equities analysts predict that Exelon Co. will post 3.11 EPS for the current year.

Exelon Company Profile

Exelon Corporation, a utility services holding company, engages in energy generation and delivery businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services.

See Also: What is the NASDAQ?

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NYSE:EXC).

Institutional Ownership by Quarter for Exelon (NYSE:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.